Company · CIK 2131524

# Braveheart Bio, Inc.

| CIK | [2131524](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002131524) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | BRVE (Nasdaq) |
| First annual or quarterly report | 2026-09-08 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-297456 | IPO Final prospectus | 2026-07-15 | 2026-08-06 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-08-06 | [424B4](https://www.sec.gov/Archives/edgar/data/2131524/000162828026054354/0001628280-26-054354-index.htm) Final prospectus | 333-297456 | 0001628280-26-054354 |
| 2026-08-05 | [EFFECT](https://www.sec.gov/Archives/edgar/data/2131524/999999999526002550/9999999995-26-002550-index.htm) Declared effective | 333-297456 | 9999999995-26-002550 |
| 2026-07-30 | [S-1/A](https://www.sec.gov/Archives/edgar/data/2131524/000162828026050756/0001628280-26-050756-index.htm) Amendment | 333-297456 | 0001628280-26-050756 |
| 2026-07-15 | [S-1](https://www.sec.gov/Archives/edgar/data/2131524/000162828026048213/0001628280-26-048213-index.htm) Registration filed | 333-297456 | 0001628280-26-048213 |
| 2026-04-29 | [DRS](https://www.sec.gov/Archives/edgar/data/2131524/000162827926000549/0001628279-26-000549-index.htm) Draft made public | 377-09309 | 0001628279-26-000549 |

[All filings of this company](https://equitycapital.markets/filings?cik=2131524) · [CSV](https://equitycapital.markets/filings.csv?cik=2131524)

---
Source page: https://equitycapital.markets/company/2131524 · Data: U.S. SEC EDGAR · CC BY 4.0